The Potential Roles of Endogenous Retroviruses in Autoimmunity
- 1 August 1996
- journal article
- Published by Wiley in Immunological Reviews
- Vol. 152 (1) , 193-236
- https://doi.org/10.1111/j.1600-065x.1996.tb00917.x
Abstract
Endogenous retroviruses (ERVs) are estimated to comprise up to 1% of human DNA. While the genome of many ERVs is interrupted by termination codons, deletions or frame shift mutations, some ERVs are transcriptionally active and recent studies reveal protein expression or particle formation by human ERVs. ERVs have been implicated as aetiological agents of autoimmune disease, because of their structural and sequence similarities to exogenous retroviruses associated with immune dysregulation and their tissue-specific or differentiation-dependent expression. In fact, retrovirus-like particles distinct from those of known exogenous retroviruses and immune responses to ERV proteins have been observed in autoimmune disease. Quantitatively or structurally aberrant expression of normally cryptic ERVs, induced by environmental or endogenous factors, could initiate autoimmunity through direct or indirect mechanisms. ERVs may lead to immune dysregulation as insertional mutagens or cis-regulatory elements of cellular genes involved in immune function. ERVs may also encode elements like tax in human T-lymphotrophic virus type I (HTLV-I) or tat in human immunodeficiency virus-I (HIV-I) that are capable of transactivating cellular genes. More directly, human ERV gene products themselves may be immunologically active, by analogy with the superantigen activity in the long terminal repeat (LTR) of mouse mammary tumour viruses (MMTV) and the non-specific immunosnppressive activity in mammalian type C retrovirus env protein. Alternatively, increased expression of an ERV protein, or expression of a novel ERV pro-tissue the result could be autoimmune disease. The adjective, paraneoplastic, would only seem appropriate if autoimmunity and tumour were temporally associated. Thus, ERVs could be viewed as being at the interface between tumour immunity and autoimmunity, the pivotal balance depending on the prevailing overlap between 'self and‘non-self. Although pure speculation, this hypothesis is consistent with the emerging body of molecular evidence that ERVs play a key role in regulating immune functions in health and disease.Keywords
This publication has 220 references indexed in Scilit:
- A retroviral implication in multiple sclerosis?Trends in Microbiology, 1994
- The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein.The Journal of Experimental Medicine, 1994
- A TH1→TH2 switch is a critical step in the etiology of HIV infectionImmunology Today, 1993
- In vitro transmission and antigenicity of a retrovirus isolated from a multiple sclerosis patientResearch in Virology, 1992
- A human endogenous long terminal repeat provides a polyadenylation signal to a novel, alternatively spliced transcript in normal placentaGene, 1992
- Retrovirus-like particles from the human T47D cell line are related to mouse mammary tumour virus and are of human endogenous originJournal of General Virology, 1992
- Selective Expression of Purkinje-Cell Antigens in Tumor Tissue from Patients with Paraneoplastic Cerebellar DegenerationNew England Journal of Medicine, 1990
- Effects of CKS-17, a synthetic retroviral envelope peptide, on cell-mediated immunity in vivo: Immunosuppression, immunogenicity, and relation to immunosuppressive tumor productsCancer Immunology, Immunotherapy, 1989
- Expression of an endogenous retroviral transcript is associated with murine lupusArthritis & Rheumatism, 1989
- Cell-mediated immunity to chemically xenogenized tumors—III. Generation of monoclonal antibodies interfering with reactivity to novel antigensInternational Journal of Immunopharmacology, 1988